Thiazolidinediones may double the risk of heart failure (HF) among patients receiving such drugs for type 2 diabetes mellitus

Author：  

Publisher： Adis International

ISSN： 0114-9954

Source： Reactions Weekly, Vol.1, Iss.1162, 2007-01, pp. : 3-3

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Rosiglitazone may increase the risk of chronic heart failure (HF) in patients receiving insulin for type 2 diabetes mellitus

By  

Reactions Weekly, Vol. 1, Iss. 1030, 2004-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Thiazolidinediones and Risk of Heart Failure in Patients with or at High Risk of Type 2 Diabetes Mellitus: A Meta-Analysis and Meta-Regression Analysis of Placebo-Controlled Randomized Clinical Trials

By Hernandez Adrian V.  

American Journal of Cardiovascular Drugs, Vol. 11, Iss. 2, 2011-04 ,pp. : 115-128

Adis International

Access to resources Recommend Favorite

Thiazolidinediones in Patients with Diabetes Mellitus and Heart Failure: Implications of Emerging Data

By Macfarlane David P.   Fisher Miles  

American Journal of Cardiovascular Drugs, Vol. 6, Iss. 5, 2006-01 ,pp. : 297-304

Adis International

Access to resources Recommend Favorite

Thiazolidinediones may confer a reduced risk of lung cancer in patients with diabetes mellitus

By  

Inpharma, Vol. 1, Iss. 1586, 2007-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Metformin may reduce the risk of cancer in patients with type 2 diabetes mellitus

By  

Inpharma, Vol. 1, Iss. 1491, 2005-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite